10x Genomics TXG
NASDAQ TXG
$93.50 +4.74 (+5.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

10x Genomics (TXG) Return on Invested Capital [ROIC] (2019 - 2020)

Updated

10x Genomics' Return on Invested Capital [ROIC] was -68.30% in Q4 2020, down 61.51 percentage points from -6.79% a year earlier and down 46.49 percentage points from the prior quarter.

Analysis

10x Genomics (TXG) Return on Invested Capital [ROIC] (2019 - 2020) Analysis & Trends

For FY2020, Return on Invested Capital [ROIC] at 10x Genomics came in at -89.86%, down 66.29 percentage points from FY2019.

  • In earlier years, Return on Invested Capital [ROIC] was -23.56% in FY2019.
  • Per Business Quant data, TXG's Return on Invested Capital [ROIC] in the three quarters before Q4 2020 was -21.81% (Q3 2020), -19.11% (Q2 2020) and -11.04% (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 7.89%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 6.20%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 5.71%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn -
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 6.90%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 10.46%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.53%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 8.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 5.27%
10 10x Genomics 12.18 Bn 11.98 Bn 112.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -68.30%
Sep 30, 2020 -21.81%
Jun 30, 2020 -19.11%
Mar 31, 2020 -11.04%
Dec 31, 2019 -6.79%
API Access

10x Genomics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TXG&period=max&api_key=YOUR_API_KEY